Cognition maintenance is essential for healthy and safe life if sleep deprivation happens.
Armodafinil is a wake-promoting agent against sleep deprivation related disorders …

Armodafinil is typically used in clinical practice to maintain cognition and wakefulness in
patients suffering from sleep deprivation. However, its poor water solubility and large …

This study was intended to develop and optimize agomelatine loaded lipid-based
transdermal vesicles (AGLTVs) for the treatment of depression. For the optimization purpose …

Armodafinil is a wake‐promoting agent approved in 2007 by the US Food and Drug
Administration for the treatment of excessive sleepiness. A rapid, sensitive and selective …

Objective: To assess the pharmacodynamics of armodafinil compared with modafinil and
placebo on measures of alertness in healthy volunteers undergoing sleep loss. Research …

Objective To review the efficacy and safety of armodafinil for the treatment in patients with
excessive sleepiness. Data sources Literature was accessed via MEDLINE (1966–February …

Background: Armodafinil is a wake-promoting agent developed by Cephalon that was
approved in mid-2007 for the treatment of excessive sleepiness associated with narcolepsy …

Excessive sleepiness (ES) is a major but underestimated public health concern associated
with significant impairments in alertness/wakefulness and significant morbidity. The term ES …

Methods In this study, Lacosamide was selected because of its high therapeutic dose, which
is due to its low transition to the target site. Microneedle patches were formulated by …

Introduction: Armodafinil is a psychostimulant that promotes alertness, and it has been
shown to improve attention, memory, and fatigue in healthy adults and adults with …